Growth targets Primus Capital is actively investing out of an $800 million ninth fund with a focus on health care, software, and technology-enabled companies. This indicates ongoing capacity for new portfolio acquisitions or growth recapitalizations, presenting opportunities to present high-growth targets or add-on investments aligned with Primus’ focus.

Portfolio activity Recent investments include RxAnte (growth investment Jan 2026) and Matic Insurance Services (minority investment Jun 2026), plus prior growth and expansion financings in healthcare software. The pattern suggests Primus seeks strategic growth rounds, analytics-enabled healthcare tech, and software-enabled health services.

Industry focus Primus concentrates on health care, software, and technology-enabled companies. Prospects include health tech analytics, revenue integrity, and billing/coding software providers, aligned with Primus’ past ~portfolio moves and the broader market trend toward value-based care and digital health adoption.

Financial profile Reported revenue range of $10M–$25M places Primus as a middle-market PE investor with appetite for growth-stage opportunities and expansion financings. This implies potential fit for companies seeking minority or growth investments, add-ons, or recapitalizations to scale operations.

Engagement signals Past activity includes exit activity and co-investments with other PE firms, plus expansion into ecommerce product mix and global entity network development. This signals openness to structured deals, cross-border expansion, and strategic partnerships that could be leveraged to position targets for Primus’ capital and network.